Carson Wealth (CWM LLC)
LAB icon

Carson Wealth (CWM LLC)’s Standard BioTools LAB Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.9K Buy
53,149
+29,187
+122% +$35.3K ﹤0.01% 3830
2025
Q4 		$31K Sell
23,962
-6,590
-22% -$8.85K ﹤0.01% 3931
2025
Q3 		$40K Sell
30,552
-1,525
-5% -$2K ﹤0.01% 3700
2025
Q2 		$38K Buy
32,077
+2,372
+8% +$2.63K ﹤0.01% 3478
2025
Q1 		$32K Buy
29,705
+14,984
+102% +$21K ﹤0.01% 3336
2024
Q4 		$26K Sell
14,721
-4,054
-22% -$7.55K ﹤0.01% 3262
2024
Q3 		$36K Buy
18,775
+9,048
+93% +$17.7K ﹤0.01% 2951
2024
Q2 		$17K Buy
9,727
+425
+5% +$1.04K ﹤0.01% 3221
2024
Q1 		$25K Buy
+9,302
New +$22.5K ﹤0.01% 2756
2023
Q3 		– Sell
-81
Closed – – 4357
2023
Q2 		$0 Buy
+81
New +$160 ﹤0.01% 4328
2022
Q2 		– Sell
-240
Closed -$1K – 3960
2022
Q1 		$1K Buy
240
+200
+500% +$691 ﹤0.01% 3366
2021
Q4 		$0 Buy
+40
New +$187 ﹤0.01% 3578

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Carson Wealth (CWM LLC)'s LAB Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Standard BioTools (LAB) stake by 122% in Q1 2026, buying an estimated $35.3K and bringing the position to 53,149 shares worth $48.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3830.

Carson Wealth (CWM LLC) first reported a position in LAB in Q4 2021 and has held it in 12 quarters since. 156 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Carson Wealth (CWM LLC) held 53,149 shares of Standard BioTools worth $48.9K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 29,187 Standard BioTools shares in Q1 2026, an estimated $35.3K.
  • Standard BioTools made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3830 holding.
  • Carson Wealth (CWM LLC) first reported a position in Standard BioTools in Q4 2021 and has held it in 12 quarters since.
  • 156 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.